Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 6.34
+0.16 (2.59%)
Jan 2, 2026, 11:59 AM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 110.48 billion as of December 31, 2025. Its market cap has increased by 85.01% in one year.
Market Cap
110.48B
Enterprise Value
115.45B
Revenue
33.49B
Ranking
n/a
PE Ratio
26.20
Stock Price
6.34
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 110.48B, an increase of 33,380.94%. That is a compound annual growth rate of 25.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 110.48B | 89.64% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 266.95B |
| Hansoh Pharmaceutical Group Company | 222.18B |
| JD Health International | 181.32B |
| Innovent Biologics | 136.55B |
| WuXi Biologics | 131.44B |
| Akeso | 102.80B |
| CSPC Pharmaceutical Group | 97.98B |
| Sichuan Kelun-Biotech Biopharmaceutical | 93.09B |